Cargando…
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway
BACKGROUND: The dynamic epigenome and proteins specialized in the interpretation of epigenetic marks critically contribute to leukemic pathogenesis but also offer alternative therapeutic avenues. Targeting newly discovered chromatin readers involved in leukemogenesis may thus provide new anticancer...
Autores principales: | Del Gaudio, Nunzio, Di Costanzo, Antonella, Liu, Ning Qing, Conte, Lidio, Dell’Aversana, Carmela, Bove, Guglielmo, Benedetti, Rosaria, Montella, Liliana, Ciardiello, Fortunato, Carafa, Vincenzo, Ambrosino, Concetta, Tucci, Valeria, Conte, Mariarosaria, Martens, Joost H. A., Stunnenberg, Hendrik G., Nebbioso, Angela, Altucci, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178829/ https://www.ncbi.nlm.nih.gov/pubmed/35681235 http://dx.doi.org/10.1186/s12943-022-01603-y |
Ejemplares similares
-
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia
por: Di Costanzo, Antonella, et al.
Publicado: (2018) -
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition
por: Del Gaudio, Nunzio, et al.
Publicado: (2019) -
The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic Options
por: Di Costanzo, Antonella, et al.
Publicado: (2020) -
HDAC2‐dependent miRNA signature in acute myeloid leukemia
por: Conte, Mariarosaria, et al.
Publicado: (2019) -
Histone deacetylase inhibitors: clinical implications for hematological malignancies
por: Tambaro, Francesco Paolo, et al.
Publicado: (2010)